By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.
Transforming Obesity Treatment: Integrating Digital Health Technology into Payer and Life Sciencesimage placeholder

Transforming Obesity Treatment: Integrating Digital Health Technology into Payer and Life Sciences

With over 800 million people affected globally, obesity is a complex, chronic disease that goes beyond the traditional "eat less, move more" approach. This deep dive uncovers Sidekick Health’s digital health strategy for obesity care, focusing on sustainable lifestyle changes, improved patient adherence, and the management of obesity’s widespread comorbidities. Discover how this approach empowers life sciences companies and insurers to provide holistic, long-term care that reduces healthcare costs and enhances patient outcomes.

by
Andy Grannell, PhD
Be the first to know!
We'll send this deep dive to you as soon as it's published. Stay informed and subscribe.
Thank you! This deep dive is ready to download.
We'll send this deep dive to you as soon as it's published. Stay informed and subscribe.
Download PDF
Oops! Something went wrong while submitting the form.
Be the first to know!
We'll send this deep dive to you as soon as it's published. Stay informed and subscribe.
Thank you! This deep dive is ready to download.
Thank you! This deep dive is ready to watch.
Watch the recording
Oops! Something went wrong while submitting the form.
you may also like
placeholder image
Discharge Essentials: Reducing unnecessary readmissions with smart digital support
Cover of Sidekick Health’s whitepaper on FDA’s 2023 draft guidance for Prescription Drug Use-Related Software (PDURS), exploring digital health innovation in Life Sciences across therapeutic areas such as oncology, cardiometabolic conditions, and dermatology.placeholder image
New FDA Guidance On PDURS Ushers In A New Era for Digital Innovation In Life Sciences
placeholder image
Nonalcoholic Steatohepatitis (NASH): The ‘Other’ 21st Century Pandemic